RPTX

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Repare Therapeutics Inc

NASDAQ | RPTX

1.73

USD

$0.00

(

0.00%

)

At Close (As of Nov 5, 2025)

$76.47M

Market Cap

-

P/E Ratio

-2.58

EPS

$4.06

52 Week High

$0.89

52 Week Low

HEALTHCARE

Sector

RPTX Chart

Recent Chart
Price Action

RPTX Technicals

Tags:

RPTX Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $40M
Total Revenue $53M
Cost Of Revenue $1.9M
Costof Goods And Services Sold $1.9M
Operating Income -$94M
Selling General And Administrative $30M
Research And Development $116M
Operating Expenses $134M
Investment Income Net -
Net Interest Income $10M
Interest Income $10M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.9M
Income Before Tax -$83M
Income Tax Expense $1.4M
Interest And Debt Expense -
Net Income From Continuing Operations -$85M
Comprehensive Income Net Of Tax -
Ebit -$92M
Ebitda -$90M
Net Income -$85M

Revenue & Profitability

Earnings Performance

RPTX Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $177M
Total Current Assets $171M
Cash And Cash Equivalents At Carrying Value $85M
Cash And Short Term Investments $85M
Inventory -
Current Net Receivables $12M
Total Non Current Assets $5.4M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $68M
Other Current Assets $6M
Other Non Current Assets -
Total Liabilities $25M
Total Current Liabilities $25M
Current Accounts Payable $3.6M
Deferred Revenue -
Current Debt -
Short Term Debt $1.8M
Total Non Current Liabilities $88K
Capital Lease Obligations $1.9M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $1.9M
Other Current Liabilities $20M
Other Non Current Liabilities -
Total Shareholder Equity $151M
Treasury Stock -
Retained Earnings -$418M
Common Stock $487M
Common Stock Shares Outstanding $42M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$76M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.9M
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $49M
Cashflow From Financing $542K
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity $525K
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$85M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $40M
Total Revenue $53M
Cost Of Revenue $1.9M
Costof Goods And Services Sold $1.9M
Operating Income -$94M
Selling General And Administrative $30M
Research And Development $116M
Operating Expenses $134M
Investment Income Net -
Net Interest Income $10M
Interest Income $10M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.9M
Income Before Tax -$83M
Income Tax Expense $1.4M
Interest And Debt Expense -
Net Income From Continuing Operations -$85M
Comprehensive Income Net Of Tax -
Ebit -$92M
Ebitda -$90M
Net Income -$85M

RPTX News

RPTX Profile

Repare Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Repare Therapeutics Inc. (RPTX) is a precision oncology company focused on transforming cancer treatment through its pioneering synthetic lethality approach. Headquartered in Montreal, Canada, the company operates in both Canada and the United States, leveraging advanced scientific methodologies to identify and develop innovative therapies that target specific genetic vulnerabilities in tumors. With a strong pipeline of drug candidates, Repare Therapeutics aims to address unmet medical needs in oncology, positioning itself as a leader in the evolving field of targeted cancer therapies.

CHR
-45.58%
$0.07
NVVE
-8.57%
$0.19
MTC
+626.97%
$2.21
ASST
+18.80%
$1.48
RIVN
+23.36%
$15.42
LNAI
+40.28%
$1.17
NVDA
-1.75%
$195.21
BYND
-4.31%
$1.33
VHAI
0.00%
$0.00
PFE
+1.37%
$24.63
RUBI
-49.75%
$0.30
SNAP
-2.00%
$7.32
PLUG
+4.76%
$2.64
TSLA
+4.00%
$462.07
GRAB
-2.50%
$5.64
YDKG
-5.55%
$0.05
F
+2.69%
$13.13
SMX
+43.53%
$2.11
PLTR
-1.48%
$187.90
INTC
+3.64%
$38.38
DNN
-2.55%
$2.67
WTO
-0.20%
$0.04
AXDX
-61.36%
$0.03
AMD
+2.51%
$256.33
ACHR
+0.26%
$9.58
GPUS
-7.02%
$0.34
T
+0.42%
$24.54
AAL
+6.08%
$13.42
BITF
+5.72%
$4.05
CMBM
+58.82%
$3.24
KVUE
+1.62%
$16.23
ONDS
+0.67%
$6.00
CIFR
+9.77%
$24.71
RXRX
-0.80%
$4.96
SOFI
+2.38%
$30.07
TEVA
+20.16%
$24.58
SMCI
-11.11%
$42.13
BAC
-2.04%
$52.44
ETHD
-15.01%
$4.47
ADAP
-15.14%
$0.05
NFE
+13.99%
$1.53
AMCR
+2.54%
$8.07
BTG
+1.12%
$4.04
WBD
+0.70%
$22.76
IREN
+14.67%
$76.41
AAPL
+0.03%
$270.14
MARA
+3.06%
$17.13
QS
+10.49%
$17.05
VALE
+3.09%
$12.31
DVLT
-7.83%
$1.64
CAN
+16.21%
$1.29
RIG
-0.12%
$3.89
RGTI
+5.99%
$37.29
U
+18.12%
$42.37
WULF
+2.33%
$15.36
RMBL
+60.50%
$3.21
FUBO
+11.00%
$4.08
AMZN
+0.35%
$250.20
ADD
-25.47%
$0.05
NVO
+0.43%
$48.46
BURU
-2.17%
$0.28
EPWK
-6.41%
$0.07
BTBT
+3.14%
$3.28
SRM
+53.27%
$10.30
TLRY
+3.62%
$1.28
BMNR
+4.89%
$41.39
NCLH
-0.95%
$18.61
JOBY
+0.98%
$14.90
ZDAI
+13.94%
$0.52
RIOT
-1.58%
$18.97
HIMS
+3.11%
$44.12
NOK
+0.51%
$6.84
APPS
+23.14%
$7.29
CMG
+0.72%
$31.97
HTZ
-0.81%
$6.67
ALIT
-7.22%
$2.50
HOOD
+4.15%
$142.47
QBTS
+4.37%
$31.04
NGD
+2.48%
$6.80
KDLY
-11.88%
$0.78
GOOGL
-2.17%
$277.54
NIO
+2.30%
$7.32
BBD
+3.47%
$3.52
BW
+28.34%
$4.80
NVTS
-5.73%
$9.86
WLGS
-5.57%
$0.04
MU
+8.93%
$237.50
HPE
+0.59%
$23.70
AG
-7.82%
$10.65
RDHL
+2.77%
$1.11
PLTZ
+2.80%
$6.24
GGB
+5.11%
$3.59
HBAN
+0.13%
$15.29
ETWO
0.00%
$3.30
CPNG
-5.94%
$30.22
PBR
+2.57%
$12.13
ABEV
+1.46%
$2.42
ITUB
+1.55%
$7.49
PCG
+1.57%
$16.16
MSPR
-27.89%
$0.47
CHR
-45.58%
$0.07
NVVE
-8.57%
$0.19
MTC
+626.97%
$2.21
ASST
+18.80%
$1.48
RIVN
+23.36%
$15.42
LNAI
+40.28%
$1.17
NVDA
-1.75%
$195.21
BYND
-4.31%
$1.33
VHAI
0.00%
$0.00
PFE
+1.37%
$24.63
RUBI
-49.75%
$0.30
SNAP
-2.00%
$7.32
PLUG
+4.76%
$2.64
TSLA
+4.00%
$462.07
GRAB
-2.50%
$5.64
YDKG
-5.55%
$0.05
F
+2.69%
$13.13
SMX
+43.53%
$2.11
PLTR
-1.48%
$187.90
INTC
+3.64%
$38.38
DNN
-2.55%
$2.67
WTO
-0.20%
$0.04
AXDX
-61.36%
$0.03
AMD
+2.51%
$256.33
ACHR
+0.26%
$9.58
GPUS
-7.02%
$0.34
T
+0.42%
$24.54
AAL
+6.08%
$13.42
BITF
+5.72%
$4.05
CMBM
+58.82%
$3.24
KVUE
+1.62%
$16.23
ONDS
+0.67%
$6.00
CIFR
+9.77%
$24.71
RXRX
-0.80%
$4.96
SOFI
+2.38%
$30.07
TEVA
+20.16%
$24.58
SMCI
-11.11%
$42.13
BAC
-2.04%
$52.44
ETHD
-15.01%
$4.47
ADAP
-15.14%
$0.05
NFE
+13.99%
$1.53
AMCR
+2.54%
$8.07
BTG
+1.12%
$4.04
WBD
+0.70%
$22.76
IREN
+14.67%
$76.41
AAPL
+0.03%
$270.14
MARA
+3.06%
$17.13
QS
+10.49%
$17.05
VALE
+3.09%
$12.31
DVLT
-7.83%
$1.64
CAN
+16.21%
$1.29
RIG
-0.12%
$3.89
RGTI
+5.99%
$37.29
U
+18.12%
$42.37
WULF
+2.33%
$15.36
RMBL
+60.50%
$3.21
FUBO
+11.00%
$4.08
AMZN
+0.35%
$250.20
ADD
-25.47%
$0.05
NVO
+0.43%
$48.46
BURU
-2.17%
$0.28
EPWK
-6.41%
$0.07
BTBT
+3.14%
$3.28
SRM
+53.27%
$10.30
TLRY
+3.62%
$1.28
BMNR
+4.89%
$41.39
NCLH
-0.95%
$18.61
JOBY
+0.98%
$14.90
ZDAI
+13.94%
$0.52
RIOT
-1.58%
$18.97
HIMS
+3.11%
$44.12
NOK
+0.51%
$6.84
APPS
+23.14%
$7.29
CMG
+0.72%
$31.97
HTZ
-0.81%
$6.67
ALIT
-7.22%
$2.50
HOOD
+4.15%
$142.47
QBTS
+4.37%
$31.04
NGD
+2.48%
$6.80
KDLY
-11.88%
$0.78
GOOGL
-2.17%
$277.54
NIO
+2.30%
$7.32
BBD
+3.47%
$3.52
BW
+28.34%
$4.80
NVTS
-5.73%
$9.86
WLGS
-5.57%
$0.04
MU
+8.93%
$237.50
HPE
+0.59%
$23.70
AG
-7.82%
$10.65
RDHL
+2.77%
$1.11
PLTZ
+2.80%
$6.24
GGB
+5.11%
$3.59
HBAN
+0.13%
$15.29
ETWO
0.00%
$3.30
CPNG
-5.94%
$30.22
PBR
+2.57%
$12.13
ABEV
+1.46%
$2.42
ITUB
+1.55%
$7.49
PCG
+1.57%
$16.16
MSPR
-27.89%
$0.47
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.